OUR VISION A WORLD FREE FROM DEATH AND SUFFERING CAUSED BY FUNGAL DISEASE.

News

Keep up to date with the latest news items from GAFFI.

Doctors around the world call for rapid response to deadly mucormycosis (the so-called “black fungus”) found in COVID patients in India.

Posted .

Countries that are able should provide amphotericin B to Indian patients.     The Global Action Fund for Fungal Infections (GAFFI) is calling on those with supplies of amphotericin B to provide them to India. In India, there are estimated to be over 4000 people with mucormycosis, (described as “black fungus” because it makes tissues go black)… Read more »

Read more >

Dr Ana Alastruey-Izquierdo to coordinate GAFFI’s programs in Latin America and Caribbean

Posted .

Following her pivotal role in GAFFI’s successful program in Guatemala, GAFFI has seconded Dr Ana Alastruey-Izquierdo to run its programs in Latin America and the Caribbean on a part-time basis. Ana is an accomplished scientist currently at Spain’s National Mycology Reference Laboratory at the Instituto de Salud Carlos III (ISCIII). In recent years, Ana has… Read more »

Read more >

Rapid spread of Mucormycosis, the black fungus, spreading amongst COVID patients suffering from diabetes in India

Posted .

Leading global fungal infection charity GAFFI has issued guidelines to help patients and carers manage the condition Multiple reports from India have identified the otherwise rare fungal infection mucormycosis affecting many patients and leaving major disfigurement or death. High numbers have been seen in Gujrat, Maharastra, Karnataka, Tamil Nadu, Andhra Pradesh, Delhi, Chandigarh and Punjab… Read more »

Read more >

Special Webinar Announcement: Ending Cryptococcal Meningitis Deaths by 2030: A New Global Initiative

Posted .

On May 12th a special Webinar will be held to outline the new push to “end Cryptococcal Meningitis Deaths by 2030”, for people with advanced from HIV disease. The Special Webinar registration link is: https://mailchi.mp/salud.unm.edu/announcement-cdcchaiunitaid-global-webinar-series-ending-crytococcal-meningitis-deaths-by-2030-1568406 There are still too many people with undiagnosed and untreated or diagnosed but under-treated fungal meningitis in AIDS, especially in… Read more »

Read more >

University of Manchester helping change the understanding and treatment of Aspergillus disease globally

Posted .

More than 300 million people worldwide suffer from serious fungal infections and around two million die each year. Research from The University of Manchester is improving patient survival and quality of life, from diagnosis though to drug development. The University of Manchester was the top ranked University in 2021 from The Times Higher Education Impact… Read more »

Read more >

Fungal disease diagnosis is lifesaver for patients with HIV and AIDS

Posted .

A fungal disease diagnostic and educational programme has had a transformational impact on the mortality of HIV patients in Guatemala, according to new research. The programme, say scientists at the Asociación de Salud Integral (ASI) in Guatemala City and The University of Manchester, will save lives in countries across the developing world if implemented. The… Read more »

Read more >

GAFFI ‘s Annual report outlines its new strategy – access to diagnostics and antifungals, the centerpiece of its efforts

Posted .

GAFFI press release Following on from major steps forward since its inception in 2013, GAFFI has adjusted its strategy with a new emphasis on strong partnerships to: 1.         Actively advocate for Essential Diagnostics and Antifungals to be accessible in each country as part of Universal Healthcare; 2.         Empower and expand GAFFI’s Ambassadors, starting in Africa… Read more »

Read more >

GAFFI’s Chief Executive honoured as a Fellow of the American Academy of Microbiology

Posted .

  The 2021 list of new Fellows of the American Academy of Microbiology has included Professor David Denning. The Academy, the honorific leadership group within the American Society for Microbiology, recognizes excellence, originality, service and leadership in the microbial sciences. Election to the Academy is a mark of distinction.  Nominated by Professor Neil Gow FRS… Read more »

Read more >

3rd Essential Diagnostics’ List Launch

Posted .

You are invited to attend the following event: When: Jan 29, 2021 02:30 PM Amsterdam, Berlin, Rome, Stockholm, Vienna Topic: 3rd Essential Diagnostics’ List Launch Webinar Link: (Please register in advance for this webinar) https://who.zoom.us/webinar/register/WN_WXNKujhjQKGqLbTqa8RxEA WHO accepts rapid tests for life threatening fungal diseases aspergillosis and Pneumocystis pneumonia as ‘Essential Diagnostics’ The World Health Organisation,… Read more »

Read more >